ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

CNSP Company Profile and Key Details

NASDAQ : CNSP

CNS Pharmaceuticals, Inc.

$0.90

0.0789+9.62%

At Close 4:00 PM

69.62

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

CNS Pharmaceuticals, Inc. (CNSP) stock surged +9.62%, trading at $0.90 on NASDAQ, up from the previous close of $0.82. The stock opened at $0.82, fluctuating between $0.80 and $0.90 in the recent session.

Stock Snapshot

0.82

Prev. Close

0.82

Open

2.65M

Market Cap

2.94M

Number of Shares

0.7999

Day Low

0.8999

Day High

N/A

P/E Ratio

99.2%

Free Float in %

-1943.5

EPS (TTM)

-0.79

Book Value

-2.51

Cash Flow per Share

178.42K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 21, 2025	0.85	0.90	0.80	0.90	178.42K
Apr 17, 2025	0.82	0.86	0.77	0.82	172.22K
Apr 16, 2025	0.93	0.93	0.82	0.82	316.1K
Apr 15, 2025	1.18	1.20	0.91	0.96	614.76K
Apr 14, 2025	1.33	1.35	1.21	1.28	118.53K
Apr 11, 2025	1.19	1.37	1.14	1.34	132.13K
Apr 10, 2025	1.10	1.20	1.04	1.18	193.08K
Apr 09, 2025	1.04	1.13	1.00	1.13	71.48K
Apr 08, 2025	1.17	1.18	1.00	1.03	242.03K
Apr 07, 2025	1.03	1.13	0.99	1.12	338.59K
Apr 04, 2025	1.05	1.14	1.01	1.10	357.34K
Apr 03, 2025	1.23	1.24	1.10	1.13	116.69K
Apr 02, 2025	1.26	1.34	1.22	1.25	112.17K
Apr 01, 2025	1.26	1.46	1.26	1.29	428.94K
Mar 31, 2025	1.21	1.38	1.21	1.36	84.66K
Mar 28, 2025	1.30	1.38	1.21	1.30	159.63K
Mar 27, 2025	1.39	1.51	1.27	1.32	373.8K
Mar 26, 2025	1.56	1.60	1.37	1.41	483.18K
Mar 25, 2025	1.51	1.66	1.28	1.63	2.4M
Mar 24, 2025	3.79	3.82	3.20	3.38	155.11K

Contact Details

Houston, TX 77027

United States

Website: https://www.cnspharma.comContact: 800 946 9185

About Company

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.

Frequently Asked Questions

What is the current CNS Pharmaceuticals, Inc. (CNSP) stock price?

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) stock price is $0.90 in the last trading session. During the trading session, CNSP stock reached the peak price of $0.90 while $0.80 was the lowest point it dropped to. The percentage change in CNSP stock occurred in the recent session was 9.62% while the dollar amount for the price change in CNSP stock was $0.08.

CNSP's industry and sector of operation?

The NASDAQ listed CNSP is part of Biotechnology industry that operates in the broader Healthcare sector. CNS Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CNSP?

Mr. Christopher S. Downs C.P.A., CTP, FP&A
Chief Financial Officer
Mr. John Michael Climaco Esq., J.D.
Chief Executive Officer, Pres & Director
Dr. Donald H. Picker Ph.D.
Chief Scientific Officer
Mr. Christopher S. Downs CPA, CTP, FP&A
Chief Financial Officer
Dr. Waldemar Priebe Ph.D.
Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board
Dr. Sandra L. Silberman M.D., Ph.D.
Chief Medical Officer of New Products

How CNSP did perform over past 52-week?

CNSP's closing price is 16.44% higher than its 52-week low of $0.77 where as its distance from 52-week high of $800.00 is -99.89%.

How many employees does CNSP have?

Number of CNSP employees currently stands at 4.

Link for CNSP official website?

Official Website of CNSP is: https://www.cnspharma.com

How do I contact CNSP?

CNSP could be contacted at phone 800 946 9185 and can also be accessed through its website. CNSP operates from 2100 West Loop South, Houston, TX 77027, United States.

How many shares of CNSP are traded daily?

CNSP stock volume for the day was 178.42K shares. The average number of CNSP shares traded daily for last 3 months was 542.99K.

What is the market cap of CNSP currently?

The market value of CNSP currently stands at $2.65M with its latest stock price at $0.90 and 2.94M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	4
Beta	1.08
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology